Literature DB >> 11447130

Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation.

X Q Wang1, P Sun, M O'Gorman, T Tai, A S Paller.   

Abstract

Gangliosides are able to bind to the epidermal growth factor receptor and inhibit its activation, but the mechanism of this inhibition is unknown. To address the role of receptor carbohydrates in facilitating interaction with gangliosides, we examined the ability of GM3 to bind the deglycosylated receptor and inhibit its autophosphorylation. Flow cytometry studies demonstrated that deglycosylation of the receptor did not affect its ability to be transported to the cell membrane. In contrast with the native (fully glycosylated) receptor, GM3 did not coimmunoprecipitate with the deglycosylated receptor. Using a novel colorimetric bead binding assay, GM3 was shown to bind well to the immunoprecipitated native receptor but not at all to the deglycosylated receptor. Finally, the addition of GM3 to cells with deglycosylated epidermal growth factor receptors did not result in significant further inhibition of autophosphorylation of the receptor, despite a 10-fold decrease in phosphorylation of the native epidermal growth factor receptor by 200 microM GM3. These studies suggest that ganglioside affects epidermal growth factor receptor activity through a direct interaction that requires receptor glycosylation, and contribute to our understanding of the role of gangliosides in cell membrane function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447130     DOI: 10.1093/glycob/11.7.515

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  19 in total

Review 1.  The glycosynapse.

Authors:  Sen-itiroh Hakomori Si
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Glycosylation defining cancer malignancy: new wine in an old bottle.

Authors:  Senitiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

3.  NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis.

Authors:  Luigi Anastasia; Nadia Papini; Francesca Colazzo; Giacomo Palazzolo; Cristina Tringali; Loredana Dileo; Marco Piccoli; Erika Conforti; Clementina Sitzia; Eugenio Monti; Maurilio Sampaolesi; Guido Tettamanti; Bruno Venerando
Journal:  J Biol Chem       Date:  2008-10-22       Impact factor: 5.157

4.  Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.

Authors:  Y Hasegawa; M Takahashi; S Ariki; D Asakawa; M Tajiri; Y Wada; Y Yamaguchi; C Nishitani; R Takamiya; A Saito; Y Uehara; J Hashimoto; Y Kurimura; H Takahashi; Y Kuroki
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

5.  Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.

Authors:  Seon-Joo Yoon; Ken-ichi Nakayama; Toshiyuki Hikita; Kazuko Handa; Sen-itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

6.  Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.

Authors:  Eric S Taylor; Laercio Pol-Fachin; Roberto D Lins; Steven K Lower
Journal:  Proteins       Date:  2017-01-18

Review 7.  Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization.

Authors:  Senitiroh Hakomori
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors.

Authors:  Abedelnasser Abulrob; Zhengfang Lu; Ewa Baumann; Dusan Vobornik; Rod Taylor; Danica Stanimirovic; Linda J Johnston
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Tunicamycin induces ER stress and inhibits tumorigenesis of head and neck cancer cells by inhibiting N-glycosylation.

Authors:  Yang Wang; Ling Zhang; Zhiyan He; Jiong Deng; Zhiyuan Zhang; Liu Liu; Weimin Ye; Shuli Liu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.

Authors:  Juanjuan Liu; Bei Lin; Yingying Hao; Yue Qi; Liancheng Zhu; Feifei Li; Dawo Liu; Jianping Cong; Shulan Zhang; Masao Iwamori
Journal:  J Exp Clin Cancer Res       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.